Source: Annual Congress 2006 - Lung cancer, haemoptoe, smoking and COPD
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
H. Abtahi, M. A. Mohagheghi, H. Shaeri, Z. Taleb (Tehran, Islamic Republic Of Iran). Comparison of opium users and non-users at the time of diagnosis of primary non-small cell lung cancer. Eur Respir J 2006; 28: Suppl. 50, 349

Member's Comments

No comment yet.

Related content which might interest you: Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC) Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 Delays in the diagnosis and treatment of non-small cell lung cancer Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Effect of comorbidity on the prognosis of non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 385s Year: 2006 Second line therapy for advanced non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Prognostic value of smoking status in operated non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 40s Year: 2004 COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 361s Year: 2003 Results of surgical treatment in elderly patients with non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 463s Year: 2002 Advanced non-small cell lung cancer in elderly patients Source: Breathe 2012; 9: 26-34 Year: 2012 Characterization and management of elderly and very elderly patients with non-small cell lung cancer Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Differences in gene expression profiles in non-small cell lung cancer (NSCLC) and in corresponding healthy lung tissue in smokers and non-smokers Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010 Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives Source: Eur Respir Rev 2011; 20: 45-52 Year: 2011 Plasma leptin levels in nonsmall cell lung carcinoma (NSCLC) patients at the time of the diagnosis Source: Eur Respir J 2001; 18: Suppl. 33, 65s Year: 2001 Time trends in treatment and survival of non-small cell lung cancer in The Netherlands Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Prevalence and effectiveness of third-line therapy for advanced non-small cell lung cancer (A-NSCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 The influence of secondary infectious process on non-small cell lung cancer (NSCLC) patients survival Source: Eur Respir J 2007; 30: Suppl. 51, 280s Year: 2007